Institutional Ownership Lyell Immunopharma, Inc. (LYEL)
This table provides information about the institutional ownership of Lyell Immunopharma, Inc. (LYEL). We have compiled data on the 108 institutions that hold shares in the stock, with a total of 171 Million shares, which have been reported (via 13F filing form) to have a value of $122 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Mwg Management Ltd.
Washington, DC |
Feb 14, 2025 Q4 2024 |
20,162,332
shares
|
$14.3 Million
17.35% of portfolio
|
Q4 2021
Reduced 0.67%
|
|
|
Apoletto LTD
Washington, DC |
Nov 14, 2022 Q3 2022 |
15,093,969
shares
|
$10.7 Million
42.56% of portfolio
|
Q4 2021
Reduced 0.49%
|
|
|
Orland Properties LTD
Washington, DC |
Feb 14, 2025 Q4 2024 |
15,093,969
shares
|
$10.7 Million
14.08% of portfolio
|
Q4 2022
New holding
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
13,495,132
shares
|
$9.58 Million
0.0% of portfolio
|
Q2 2024
Reduced 2.86%
|
|
|
Decheng Capital LLC
Menlo Park, CA |
Feb 14, 2025 Q4 2024 |
11,909,341
shares
|
$8.46 Million
1.63% of portfolio
|
Q4 2024
New holding
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Feb 11, 2025 Q4 2024 |
9,766,083
shares
|
$6.93 Million
0.0% of portfolio
|
Q4 2024
Reduced 3.03%
|
|
|
Foresite Capital Management Iv, LLC
Larkspur, CA |
Feb 14, 2025 Q4 2024 |
8,325,000
shares
|
$5.91 Million
4.9% of portfolio
|
Q4 2023
Reduced 5.23%
|
|
|
Foresite Capital Management V, LLC
Larkspur, CA |
Feb 14, 2025 Q4 2024 |
8,133,047
shares
|
$5.77 Million
14.48% of portfolio
|
Q4 2024
New holding
|
|
|
Wu Xi App Tec Co., Ltd.
Shanghai, F4 |
Nov 08, 2024 Q3 2024 |
7,390,710
shares
|
$5.25 Million
53.56% of portfolio
|
Q3 2024
Reduced 3.79%
|
|
|
Ven Bio Partners LLC
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
7,102,190
shares
|
$5.04 Million
3.74% of portfolio
|
Q4 2024
New holding
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Feb 14, 2025 Q4 2024 |
6,910,749
shares
|
$4.91 Million
0.0% of portfolio
|
Q4 2024
Reduced 6.01%
|
|
|
Alphabet Inc.
Mountain View, CA |
Feb 06, 2025 Q4 2024 |
5,865,125
shares
|
$4.16 Million
0.27% of portfolio
|
Q2 2021
New holding
|
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
4,137,264
shares
|
$2.94 Million
0.0% of portfolio
|
Q4 2024
Added 2.92%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Feb 14, 2025 Q4 2024 |
3,754,745
shares
|
$2.67 Million
0.0% of portfolio
|
Q4 2024
Added 211196.84%
|
|
|
State Street Corp
Boston, MA |
Feb 14, 2025 Q4 2024 |
3,748,673
shares
|
$2.66 Million
0.0% of portfolio
|
Q4 2024
Reduced 3.62%
|
|
|
Orbimed Advisors LLC
San Diego, CA |
Feb 14, 2025 Q4 2024 |
3,103,623
shares
|
$2.2 Million
0.05% of portfolio
|
Q4 2024
Reduced 49.0%
|
|
|
Sc China Holding LTD
N/A, K3 |
Feb 14, 2025 Q4 2024 |
3,045,997
shares
|
$2.16 Million
0.12% of portfolio
|
Q3 2021
Added 25.0%
|
|
|
Mic Capital Management Uk LLP
London, X0 |
Feb 14, 2025 Q4 2024 |
1,740,569
shares
|
$1.24 Million
0.17% of portfolio
|
Q3 2023
Reduced 43.13%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Feb 06, 2025 Q4 2024 |
1,645,787
shares
|
$1.17 Million
0.0% of portfolio
|
Q4 2024
Added 43.44%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Feb 13, 2025 Q4 2024 |
1,612,146
shares
|
$1.14 Million
0.0% of portfolio
|
Q4 2024
Added 716.69%
|
|
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
Feb 14, 2025 Q4 2024 |
1,385,301
shares
|
$983,563
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Northern Trust Corp
Chicago, IL |
Feb 14, 2025 Q4 2024 |
1,310,224
shares
|
$930,259
0.0% of portfolio
|
Q4 2024
Reduced 3.38%
|
|
|
Ikarian Capital, LLC
Dallas, TX |
Feb 14, 2025 Q4 2024 |
1,276,037
shares
|
$905,986
0.13% of portfolio
|
Q4 2024
Added 142.56%
|
|
|
Morgan Stanley
New York, NY |
Feb 14, 2025 Q4 2024 |
1,214,287
shares
|
$862,143
0.0% of portfolio
|
Q4 2024
Reduced 29.73%
|
|
|
Almitas Capital LLC
Santa Monica, CA |
Feb 14, 2025 Q4 2024 |
1,050,520
shares
|
$745,869
0.33% of portfolio
|
Q4 2024
New holding
|